- Corporate Officers - E
- Endicott David J.
Insider Trading History of Endicott David J.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Endicott David J. since 2012.
The trader's CIK number is 1532133.
At the time of the last reporting, Endicott David J. was the CVP and President, AGN Med of Hospira Inc. (stock ticker symbol HSP).
Also see all insider trading activities at Hospira Inc.
Note that in the past
Endicott David J. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Hospira Inc (HSP) by Endicott David J.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | HSP | 0 | $0 | 0 | $0 | 72,971 | $3,138,482 |
Yearly summary of insider trading at Allergan Inc (AGN) by Endicott David J.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | AGN | 0 | $0 | 80,060 | $7,437,710 | 80,060 | $4,753,780 |
Insider trading activities at 2 companies by Endicott David J.:
1. Hospira Inc (HSP)
2. Allergan Inc (AGN)
Table 1. Insider trading of Hospira Inc (HSP) by Endicott David J.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-09-03 | HSP | Option Ex | 72,971 | 43.01 | 3,138,482 |
Table 2. Insider trading of Allergan Inc (AGN) by Endicott David J.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-11-29 | AGN | Sale | 52,560 | 92.43 | 4,857,963 |
| 2012-11-29 | AGN | Option Ex | 52,560 | 64.47 | 3,388,543 |
| 2012-05-07 | AGN | Option Ex | 27,500 | 49.65 | 1,365,237 |
| 2012-05-07 | AGN | Sale | 27,500 | 93.81 | 2,579,747 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Endicott David J.
(CVP and President, AGN Med of Hospira Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.